Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • blood sugar

    Tag: blood sugar

    You Searched For "blood sugar"
    Roche secures CE Mark for Accu-Chek SugarView app for diabetes management

    Roche secures CE Mark for Accu-Chek SugarView app for diabetes management

    Farhat Nasim10 Dec 2019 1:07 PM IST
    Now officially classified as in-vitro diagnostics (IVD) software, the app will be made widely accessible by Roche first for certain smartphone models...
    Abbott, Tandem Diabetes Care explore integrated solutions to improve diabetes management

    Abbott, Tandem Diabetes Care explore integrated solutions to improve diabetes management

    Farhat Nasim16 Oct 2019 9:40 AM IST
    New Delhi: Abbott and Tandem Diabetes Care recently announced that they intend to develop and commercialize integrated diabetes solutions that combine...
    Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio

    Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio

    Farhat Nasim14 Oct 2019 1:36 PM IST
    While two products Rivaroxaban and Vildagliptin will augment Morepen Lab's presence in the cardiac and diabetic segments respectively, the third...
    Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes

    Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes

    Medical Dialogues Bureau21 Sept 2019 9:30 AM IST
    "We are delighted that the findings of the CONCLUDE trial support what we have seen previously across the Tresiba clinical development programme,"...
    Medtronic, Novo Nordisk team up for integrating glucose monitoring, insulin dosing data to help diabetics

    Medtronic, Novo Nordisk team up for integrating glucose monitoring, insulin dosing data to help diabetics

    Medical Dialogues Bureau18 Sept 2019 9:30 AM IST
    This new, non-exclusive collaboration reflects both Medtronic plc and Novo Nordisk commitment to make diabetes management easier by integrating key...
    Fight for Vildagliptin: Natco goes to court against Novartis

    Fight for Vildagliptin: Natco goes to court against Novartis

    Farhat Nasim7 Sept 2019 4:32 PM IST
    Mumbai: Throwing an indirect challenge at patent holder Novartis, drugmaker Natco Pharma has submitted a fresh application in a Hyderabad court...
    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Farhat Nasim30 July 2019 2:08 PM IST
    New Delhi: The patent protection of blockbuster anti-diabetic drug Vildagliptin manufactured by the Swiss drugmaker, Novartis, will soon expire on...
    USFDA Warning: Medtronic recalls insulin pumps over cybersecurity vulnerabilities

    USFDA Warning: Medtronic recalls insulin pumps over cybersecurity vulnerabilities

    Medical Dialogues Bureau29 Jun 2019 1:49 PM IST
    The recalled pumps are Medtronic's MiniMed 508 insulin pump and MiniMed Paradigm series insulin pumps. Medtronic is unable to adequately update the...
    Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unit

    Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unit

    Medical Dialogues Bureau12 Jun 2019 9:30 AM IST
    Roche's new diagnostics boss, Thomas Schinecker, fills a post that had been led for months on an interim basis by Michael Heuer, who is retiring....
    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    Medical Dialogues Bureau9 Jun 2019 11:15 AM IST
    The commission also said in its view, diabetes was a lifestyle disease in India and the whole insurance claim (Mediclaim) cannot be rejected only...
    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    Farhat Nasim4 Jun 2019 5:44 PM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Novartis wins USFDA approval for first PI3K inhibitor for breast cancer

    Novartis wins USFDA approval for first PI3K inhibitor for breast cancer

    Farhat Nasim27 May 2019 6:10 PM IST
    The drug, alpelisib, to be marketed under the brand name Piqray, belongs to a class of drugs known as PI3K inhibitors and is the first of its kind to...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok